when did glp 1 agonists come out Evolution of GLP‐1 Receptor for Diabetes Treatment DID YOU KNOW? GLP-1 medications
Description
Beyond Weight Loss: Additional Health Benefits The benefits of GLP-1 drugs extend beyond just weight loss
The authors compared changes in glycemic control and BMD with and without conversion from DPP-4 inhibitor to GLP-1 receptor agonist for 3 years and observed that patients who switched to the latter had greater decline in lumbar BMD than controls regardless of weight loss [12, 61]
Many rheumatologists are aware of the emerging data but have not been directly asked about it by patients
GLP-1RAs work to stimulate insulin secretion in a glucose-dependent manner, thus carrying a low risk of hypoglycemia
By targeting both receptors, Mounjaro not only helps reduce appetite but also enhances feelings of fullness, supporting more significant weight loss
Given the high prevalence of fatty liver in diabetic patients (estimated at 5570%), initiating or switching to a GLP-1 agonist addresses both conditions simultaneously
